Fig. 1From: Metabolomic profiles of intact tissues reflect clinically relevant prostate cancer subtypesDiscrimination between tumor and benign prostate tissues based on metabolic 1H HR MAS NMR data. OPLS-DA score plot indicating metabolomics differences between the two groups (blue—benign samples; red—PC samples) with each score representing one subjectBack to article page